Antibiotics Differentially Modulate Lipoteichoic Acid-Mediated Host Immune Response

Area of Science:

• Immunology
• Pharmacology
• Infectious Diseases

Background:

• Staphylococcus aureus bacteremia can lead to a detrimental immunoparalysis phenotype, predicting poor outcomes.
• Lipoteichoic acid (LTA) from S. aureus and certain antibiotics can modulate immune responses.
• Understanding host-microbial-antibiotic interactions is crucial for effective S. aureus bacteremia treatment.

Purpose of the Study:

• To evaluate the differential effects of vancomycin, tedizolid, and daptomycin on immune cell activation.
• To investigate how these antibiotics modulate cytokine and immune marker expression in response to LTA.
• To explore the clinical implications of antibiotic-mediated immune modulation in S. aureus bacteremia.

Main Methods:

• Human peripheral blood mononuclear cells (PBMCs) were exposed to varying doses of LTA.
• The expression of immune activation markers (TNFα, HLA-DR) and immunoparalysis markers (IL-10, PD-L1) was measured.
• The impact of vancomycin, tedizolid, and daptomycin on these markers was assessed ex vivo.

Main Results:

• LTA induced a dose-dependent pro- and anti-inflammatory immune response.
• Vancomycin significantly increased IL-10 and TNFα expression.
• Tedizolid enhanced TNFα and HLA-DR expression, while daptomycin showed no significant effects.
• Differential antibiotic effects were more pronounced at high LTA concentrations.

Conclusions:

• Anti-staphylococcal antibiotics differentially modulate LTA-induced immune cell activation and cytokine responses.
• These findings highlight the complex interplay between host immunity, S. aureus, and antibiotics.
• Further clinical research is warranted to optimize precision therapy for S. aureus bacteremia based on these interactions.